• Join
  • Login
  • Contact

FIP Development Goal 16: Communicable diseases


 FIP Development Goal 16 Workforce Element

FIP Development Goal 16 [w]



Globally, we will have:

Education and training infrastructures in place to develop a workforce prepared to deliver quality services around communicable and vector-borne diseases. 


  • Ensure adequate education and training for the effective performance of the roles described above at part of foundation training of the pharmaceutical workforce (FIP Development Goal 2) as well as in postgraduate and continuing professional development pathways (FIP Development Goals 4 & 9 [w]).

  • Develop competency for vaccination delivery and related roles as part of undergraduate education and/or CPD pathways whenever the regulatory frameworks for pharmacists’ scope of practice supports the delivery of these services (FIP Development Goal 5 & 7 [w]).


FIP Development Goal 16 Practice Element

FIP Development Goal 16 [p]



Globally, we will have:

Strategies and people-centred professional services for the prevention, surveillance, management and therapeutic optimisation of communicable and vector-borne diseases.


  • Develop and implement structured and evidence-based disease prevention strategies and professional services for vector-borne and communicable diseases by all types of etiological agents (viruses, bacteria, fungi, parasites).

  • Develop and implement structures and mechanisms to contribute to overall integrated prevention health strategies that aim to prevent or slow the progression and spread of diseases and vectors

  • Engage with stakeholders and policy makers to implement strategies and policies that support the delivery of vaccines by the pharmaceutical workforce.

  • Develop and implement clear and comprehensive strategies on readiness for dealing with and delivering urgent and emergency pharmaceutical care and services during pandemics, epidemics, and disease outbreaks.

  • Develop and utilise tools, resources, and expertise to educate patients and caregivers in an appropriate and timely manner on communicable and vector-borne diseases including sexual health education in the context of preventing sexually transmitted diseases.


FIP Development Goal 16 Science Element 


FIP Development Goal 16 [s]



Globally, we will have:

Capacity to monitor and respond to communicable with innovative approaches for prevention and treatment.


  • Facilitate information sharing about disease prevalence and innovative treatment strategies.

  • Inventory and disseminate educational programmes and tools to accelerate innovative preventive and treatment strategies.

  • Monitor the development of innovative diagnostic, preventative and therapeutic pharmaceutical products.

Find out more about the 21 FIP Development Goals for transforming global pharmacy here.
Last update 16 September 2020

FIP Congresses